The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation

SE Lee, KM Woo, SY Kim, HM Kim, K Kwack, ZH Lee… - Bone, 2002 - Elsevier
Phosphatidylinositol 3-kinase (PI 3-kinase) and mitogen-activated protein kinases (MAPKs)
have been implicated in diverse cellular functions, including proliferation, migration, and …

Phosphatidylinositol 3‐kinase coordinately activates the MEK/ERK and AKT/NFκB pathways to maintain osteoclast survival

A Gingery, E Bradley, A Shaw… - Journal of cellular …, 2003 - Wiley Online Library
We have examined highly purified osteoclasts that were generated in vitro from murine co‐
culture of marrow precursors with stromal support cells and have found evidence of …

U0126 and PD98059, specific inhibitors of MEK, accelerate differentiation of RAW264. 7 cells into osteoclast-like cells

H Hotokezaka, E Sakai, K Kanaoka, K Saito… - Journal of Biological …, 2002 - ASBMB
Osteoclasts are multinucleated cells that differentiate from hematopoietic cells and possess
characteristics responsible for bone resorption. To study the involvement of mitogen …

Involvement of p38 mitogen-activated protein kinase signaling pathway in osteoclastogenesis mediated by receptor activator of NF-κB ligand (RANKL)

M Matsumoto, T Sudo, T Saito, H Osada… - Journal of Biological …, 2000 - ASBMB
The receptor activator of NF-κB ligand (RANKL) induces osteoclast differentiation from bone
marrow cells in the presence of macrophage colony-stimulating factor. We found that …

Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway

H Huang, EJ Chang, J Ryu, ZH Lee, Y Lee… - … and biophysical research …, 2006 - Elsevier
The crucial role of p38 mitogen-activated protein kinase for osteoclast differentiation has
been suggested from studies with specific pharmacological inhibitors and dominant …

Phosphatidylinositol 3-kinase association with the osteoclast cytoskeleton, and its involvement in osteoclast attachment and spreading

PT Lakkakorpi, G Wesolowski, Z Zimolo… - Experimental cell …, 1997 - Elsevier
Osteoclast activation involves attachment to the mineralized bone matrix and reorganization
of the cytoskeleton, leading to polarization of the cell. Signaling molecules, PI3-kinase, rho …

12‐O‐tetradecanoylphorbol‐13‐acetate (TPA) Inhibits Osteoclastogenesis by Suppressing RANKL‐Induced NF‐κB Activation

C Wang, JH Steer, DA Joyce, KHM Yip… - Journal of Bone and …, 2003 - academic.oup.com
The mechanism by which TPA‐induced PKC activity modulates osteoclastogenesis is not
clear. Using a RAW264. 7 cell culture system and assays for NF‐κB nuclear translocation …

MKK3/6-p38 MAPK Signaling Is Required for IL-1β and TNF-α-Induced RANKL Expression in Bone Marrow Stromal Cells

C Rossa Jr, K Ehmann, M Liu, C Patil… - Journal of interferon & …, 2006 - liebertpub.com
Coupled bone turnover is directed by the expression of receptor-activated NF-κB ligand
(RANKL) and its decoy receptor, osteoprotegerin (OPG). Proinflammatory cytokines, such as …

p38 MAPK-mediated signals are required for inducing osteoclast differentiation but not for osteoclast function

X Li, N Udagawa, K Itoh, K Suda, Y Murase… - …, 2002 - academic.oup.com
Receptor activator of nuclear factor-κB ligand (RANKL)-induced signals play critical roles in
osteoclast differentiation and function. SB203580, an inhibitor of p38 MAPK, blocked …

Osteoclast differentiation is impaired in the absence of inhibitor of κB kinase α

ML Chaisson, DG Branstetter, JM Derry… - Journal of Biological …, 2004 - ASBMB
Signaling through the receptor activator of nuclear factor κB (RANK) is required for both
osteoclast differentiation and mammary gland development, yet the extent to which RANK …